Collaboration for new therapies: maximizing health and innovation
It is critical to ascertain how the strengths of each actor can be leveraged to bring new medicines/treatments to market, quicker and more efficiently. We need a trusted environment, with strategic collaborations between the public and private sectors, and policy initiatives and incentives should be targeted to strengthen the infrastructure with the aim of fostering such optimal alliances.
Authors
- Pierre Meulien
- Jorge Mestre-Ferrándiz (ORCID: https://orcid.org/0000-0003-0529-1321)
- Dennis A. Ostwald
- Virginia Acha (ORCID: https://orcid.org/0000-0001-7498-9438)
Institutions
- Centre for Innovation in Regulatory Science (GB)
- Global Security Intelligence (United Kingdom) (GB)
- Hospital de Faro EPE (PT)
- Urban Institute (Germany) (DE)
- Universidad Carlos III de Madrid (ES)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2024-09-19
- DOI
- https://doi.org/10.3389/fpubh.2024.1383107
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 1.13